SURGICAL TREATMENT OF INSULINOMA: A CASE REPORT
DOI:
https://doi.org/10.56238/ERR01v10n7-037Keywords:
Insulinoma, Hypoglycemia, EnucleationAbstract
Insulinoma is the most common functional neuroendocrine tumor of the pancreas, characterized by autonomous insulin secretion and recurrent episodes of hypoglycemia. Although rare, it can affect individuals of any age and gender. Clinically, it presents with neuroglycopenic and autonomic symptoms, often misdiagnosed as neurological or psychiatric disorders, leading to delayed diagnosis. Whipple’s triad, along with laboratory tests and imaging studies, is essential for diagnostic confirmation. Surgical resection is the treatment of choice, offering high cure rates in localized and benign cases. In malignant cases, additional therapeutic strategies are required.
Downloads
References
1. SERVICE, F. J. Hypoglycemic disorders. New England Journal of Medicine, v. 332, n. 17, p. 1144-1152, 1995.
2. HALFDANARSON, T. R. et al. Pancreatic neuroendocrine tumors: Epidemiology and classification. UpToDate, 2024.
3. OKABAYASHI, T. et al. Diagnosis and management of insulinoma. World Journal of Gastroenterology, v. 19, n. 6, p. 829-837, 2013.
4. VINIK, A. I. et al. Clinical review: Insulinoma. Journal of Clinical Endocrinology and Metabolism, v. 95, n. 9, p. 361-373, 2010.
5. CORRÊA-GIANNELLA, M. L. et al. Insulinomatosis: Four case reports. Frontiers in Endocrinology, v. 15, p. 1-10, 2024.
6. REZENDE, L. M. B. et al. Diagnóstico e conduta nos insulinomas. Revista Brasileira de Clínica Médica, v. 20, n. 3, p. 185-191, 2022.
7. DAVI, M. V. et al. Localization and treatment of insulinoma. Endocrine-Related Cancer, v. 30, n. 4, p. 251-263, 2023.
8. CALDAS, A. R. et al.. Insulinoma pancreático: casuística de um hospital central e revisão. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, v. 11, n. 2, p. 85-92, 2016.
9. CARBONNIÈRES, A. et al. Surgical management of insulinoma over three decades. HPB, v. 23, n. 10, p. 1432-1440, 2021.
10. MASHARANI, U.; LINDSAY, S.; MOON, F.; PACIOREK, A.; BERGSLAND, E. Metastatic insulinoma: outcomes in the current era. Oncologist, v. 30, n. 3, p. 275-283, 2025. DOI: 10.1093/oncolo/oyae275. PMID: 39475415. PMCID: PMC11954510.
